(Q54407620)

English

Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

Spencer B. Gibson

5

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

author name string

Ju-Yoon Yoon

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

Ganchimeg Ishdorj

2

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

Bonnie A Graham

3

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

James B Johnston

4

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

publication date

1 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

19

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

1

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

191-200

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

https://scigraph.springernature.com/pub.10.1007/s10495-013-0906-7

0 references

Fludarabine in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Maintenance therapy in lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Fludarabine: a review of its use in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Epigenetic modulation of gene expression of human leukemia cell lines - induction of cell death and senescence

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Histone deacetylase is a target of valproic acid-mediated cellular differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Analysis of apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

The role of TRAIL death receptors in the treatment of hematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

The DNA Damage Response: Making It Safe to Play with Knives

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Diverse mechanisms of AKT pathway activation in human malignancy

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Valproic acid enhances bosutinib cytotoxicity in colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

The B-cell receptor signaling pathway as a therapeutic target in CLL.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Treatment of elderly patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10495-013-0906-7

21 January 2018

Identifiers

10.1007/S10495-013-0906-7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/24057147

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54407620&oldid=1956841967"